Compare TD & WELL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TD | WELL |
|---|---|---|
| Founded | 1855 | 1970 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Real Estate Investment Trusts |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 159.0B | 131.1B |
| IPO Year | N/A | N/A |
| Metric | TD | WELL |
|---|---|---|
| Price | $94.58 | $188.03 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 10 |
| Target Price | $120.00 | ★ $208.90 |
| AVG Volume (30 Days) | 2.0M | ★ 3.7M |
| Earning Date | 12-04-2025 | 02-10-2026 |
| Dividend Yield | ★ 3.15% | 1.58% |
| EPS Growth | ★ 144.91 | N/A |
| EPS | ★ 8.25 | 1.46 |
| Revenue | ★ $45,149,067,348.00 | $9,907,853,000.00 |
| Revenue This Year | N/A | $31.06 |
| Revenue Next Year | $4.29 | $17.84 |
| P/E Ratio | ★ $11.19 | $128.75 |
| Revenue Growth | 18.83 | ★ 32.28 |
| 52 Week Low | $52.63 | $123.11 |
| 52 Week High | $94.83 | $209.05 |
| Indicator | TD | WELL |
|---|---|---|
| Relative Strength Index (RSI) | 81.85 | 42.16 |
| Support Level | $90.37 | $185.11 |
| Resistance Level | $94.83 | $187.92 |
| Average True Range (ATR) | 1.02 | 3.83 |
| MACD | 0.22 | -1.16 |
| Stochastic Oscillator | 96.23 | 19.00 |
Toronto-Dominion is one of Canada's two largest banks with over CAD 2 trillion in assets. TD Bank operates four business segments: Canadian personal and commercial banking, US retail banking, wealth management and insurance, and wholesale banking. The bank derives more than 50% of its revenue from Canada and has dominant market share in nearly all banking products and services. TD has around 44% of its revenue from its US operations. Its US footprint spans from Maine to Florida, with a strong presence in the Northeast.
Welltower owns a diversified healthcare portfolio of 2,391 in-place properties spread across the senior housing, medical office, and skilled nursing/postacute care sectors. The portfolio includes over 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to that of the United States.